Safety and Feasibility of Lung Resection after Immunotherapy for Metastatic or Unresectable Tumors

BACKGROUND: Surgeons are increasingly asked to operate on patients with residual disease after immunotherapy. The safety and utility of lung resection in this setting are unknown. METHODS: We performed a retrospective review of patients who underwent lung resection within 6 months of treatment with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Thorac Surg
Autori principali: Bott, Matthew J., Cools-Lartigue, Jonathan, Tan, Kay See, Dycoco, Joseph, Bains, Manjit S., Downey, Robert J., Huang, James, Isbell, James M., Molena, Daniela, Park, Bernard J., Rusch, Valerie W., Sihag, Smita, Jones, David R., Adusumilli, Prasad S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357770/
https://ncbi.nlm.nih.gov/pubmed/29550207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.02.030
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi